Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

MeSH terms

• Adult
• Dose-Response Relationship, Drug
• Double-Blind Method
• Drug Administration Schedule
• Etanercept
• Female
• Follow-Up Studies
• Humans
• Immunoglobulin G / therapeutic use*
• Immunosuppressive Agents / therapeutic use
• Injections, Subcutaneous
• Male
• Middle Aged
• Patient Satisfaction / statistics & numerical data*
• Psoriasis / complications
• Psoriasis / diagnosis
• Psoriasis / drug therapy*
• Receptors, Tumor Necrosis Factor / therapeutic use*
• Reference Values
• Scalp Dermatoses / complications
• Scalp Dermatoses / diagnosis
• Scalp Dermatoses / drug therapy*
• Self-Assessment
• Severity of Illness Index
• Treatment Outcome